176 related articles for article (PubMed ID: 7889201)
1. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
3. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
4. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
5. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
[TBL] [Abstract][Full Text] [Related]
6. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
[TBL] [Abstract][Full Text] [Related]
7. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
Nakamura T; Honma H; Ikeda Y; Kuroyanagi R; Takano H; Obata J; Sato T; Kimura H; Yoshida Y; Tamura K
Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203
[TBL] [Abstract][Full Text] [Related]
8. [Ameliorative effects on retinal disorder in diabetic SHRSP (stroke-prone spontaneously hypertensive rat)].
Nagisa Y; Shintani A; Nakagawa S
Nihon Rinsho; 2002 Oct; 60(10):1975-80. PubMed ID: 12397694
[TBL] [Abstract][Full Text] [Related]
9. Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats.
Nakamura T; Obata J; Kuroyanagi R; Kimura H; Ikeda Y; Takano H; Naito A; Sato T; Yoshida Y
Kidney Int Suppl; 1996 Jun; 55():S109-12. PubMed ID: 8743527
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats.
Hamaguchi A; Kim S; Ohta K; Yagi K; Yukimura T; Miura K; Fukuda T; Iwao H
Hypertension; 1995 Jul; 26(1):199-207. PubMed ID: 7541781
[TBL] [Abstract][Full Text] [Related]
11. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
[TBL] [Abstract][Full Text] [Related]
13. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
Kett MM; Alcorn D; Bertram JF; Anderson WP
J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
[TBL] [Abstract][Full Text] [Related]
15. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
Nishikawa K
J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
Stier CT; Adler LA; Levine S; Chander PN
J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
20. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
Sasamura H; Shimizu-Hirota R; Nakaya H; Saruta T
Hypertens Res; 2001 Mar; 24(2):165-72. PubMed ID: 11325076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]